Troubled hedge fund Ritchie Capital has sold its technology and life sciences debt financing unit in a further attempt to sell off assets to meet investor redemptions.

BlueCrest Capital Finance has bought the unit, Ritchie Technology & Life Sciences. A source familiar with the sale said the deal was made because BlueCrest offered the best synergy and growth opportunities for the unit.